BRIEF published on 11/05/2024 at 07:05, 18 days 2 hours ago Leonteq Launches Shari’a-Compliant Products on LYNQS Platform Leonteq LynQs Middle East Market Investment Products Shari’a-compliant
PRESS RELEASE published on 11/05/2024 at 07:00, 18 days 2 hours ago Press release: Leonteq launches Shari’a-compliant offering on LYNQS Leonteq launches Shari’a-compliant trust certificates on LYNQS digital investing platform, expanding product offering for the GCC market Middle East Leonteq Structured Products LynQs Shari’a-compliant
BRIEF published on 10/30/2024 at 07:05, 24 days 2 hours ago Leonteq Expands ETP+ Offerings to Deutsche Börse Leonteq AG Deutsche Börse ETP+ Launch Investment Products Eurozone Rates
PRESS RELEASE published on 10/30/2024 at 07:00, 24 days 2 hours ago Press release: Leonteq launches first ETP+ on Deutsche Börse Leonteq announces launch of first collateralized ETP+ on Deutsche Börse, tracking Leonteq EUR Overnight Return Index linked to ESTRON. Strategic move to expand offerings Leonteq Deutsche Börse ETP+ Collateralized European Short-Term Overnight Rate
BRIEF published on 10/17/2024 at 07:05, 1 month 6 days ago Leonteq AG Begins Strategic Partnership with Bergos Structured Products Investment Solutions Leonteq-Bergos Partnership White-labelling Model Swiss Private Bank
PRESS RELEASE published on 10/17/2024 at 07:00, 1 month 6 days ago Press release: Leonteq launches cooperation with Bergos Leonteq AG launches cooperation with Bergos for manufacturing and distributing structured investment products. Bergos will utilize Leonteq's technology platform for trading. First products expected in the second half of 2024 Investment Structured Products Leonteq AG Coopération Bergos
BRIEF published on 10/14/2024 at 20:10, 1 month 8 days ago Fitch Affirms Leonteq's 'BBB' Rating with Stable Outlook Market Risk Leonteq AG Credit Rating Fitch Ratings Investment Outlook
PRESS RELEASE published on 10/14/2024 at 20:05, 1 month 8 days ago Press release: Fitch affirms Leonteq's 'BBB' rating with stable outlook Fitch affirms Leonteq's 'BBB' rating with stable outlook. Leonteq AG maintains good franchise in Swiss market, strong capitalisation, and sound liquidity management Leonteq Stable Outlook Fitch Swiss Market BBB Rating
BRIEF published on 09/04/2024 at 07:05, 2 months 19 days ago MSCI Affirms Leonteq's AA ESG Rating Sustainability Finance Leonteq ESG Rating MSCI
PRESS RELEASE published on 09/04/2024 at 07:00, 2 months 19 days ago Press release: MSCI affirms Leonteq's AA ESG rating MSCI affirms Leonteq's AA ESG rating, recognizing its efforts in embedding ESG considerations and sustainability practices. Leonteq leading in managing ESG risks Leonteq MSCI AA ESG Rating Sustainability Practices ESG Considerations
Published on 11/22/2024 at 23:55, 9 hours 20 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 45 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 10 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 45 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 17:53, 15 hours 21 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 19 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 15 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 13 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
